Status:

COMPLETED

Enhancing Adaptations to Exercise

Lead Sponsor:

Mayo Clinic

Collaborating Sponsors:

National Institute on Aging (NIA)

National Center for Research Resources (NCRR)

Conditions:

Inflammation

Eligibility:

All Genders

20-85 years

Phase:

PHASE3

Brief Summary

Researchers are trying to understand how chronic inflammation affects muscle function and responses to exercise.They are also trying to determine if suppressing chronic inflammation using omega-3 fatt...

Detailed Description

Participants will be divided into two groups. Men and women between the ages of 20-35 years and 65-85 years. Participants in the older age group will be randomly assigned to receive groups (n3-PUFA or...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Men and women between the ages of 20-35 years
  • Men and women between the ages of 65-85 years
  • Exclusion criteria:
  • Regular use of omega-3 nutritional supplements
  • Diabetes or fasting plasma glucose \> or equal to 126 mg/dL
  • Anemia (female subjects hemoglobin of \<11 g/dl and male subjects hemoglobin \<12 g/dl)
  • Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment)
  • Renal failure (serum creatinine \> 1.5mg/dl)
  • Chronic active liver disease (AST\>144 IU/L or ALT\>165 IU/L)
  • Oral warfarin group medications or history of blood clotting disorders.
  • international normalized ratio (INR) \>2.01.5
  • Smoking
  • Pregnancy or breastfeeding
  • Alcohol consumption greater than 2 glasses/day or other substance abuse
  • Untreated or uncontrolled hypothyroidism
  • Debilitating chronic disease (at the discretion of the investigators)
  • Fish or shellfish allergy

Exclusion

    Key Trial Info

    Start Date :

    January 1 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2021

    Estimated Enrollment :

    63 Patients enrolled

    Trial Details

    Trial ID

    NCT03350906

    Start Date

    January 1 2018

    End Date

    December 31 2021

    Last Update

    November 14 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Mayo Clinic in Rochester

    Rochester, Minnesota, United States, 55905